Better Drugs, Hep C Testing and Baby Boomers
Two new drugs expected to enter the market soon appear to nearly double the success rate of Hepatitis C treatment. As a result of this therapeutic improvement, the age group most at risk for the Hepatitis C virus may be routinely screened for this infection.
Continue reading »